Literature DB >> 8182121

Massive xanthomatosis and atherosclerosis in cholesterol-fed low density lipoprotein receptor-negative mice.

S Ishibashi1, J L Goldstein, M S Brown, J Herz, D K Burns.   

Abstract

Mice that are homozygous for a targeted disruption of the LDL receptor gene (LDLR-/- mice) were fed a diet that contained 1.25% cholesterol, 7.5% cocoa butter, 7.5% casein, and 0.5% cholic acid. The total plasma cholesterol rose from 246 to > 1,500 mg/dl, associated with a marked increase in VLDL, intermediate density lipoproteins (IDL), and LDL cholesterol, and a decrease in HDL cholesterol. In wild type littermates fed the same diet, the total plasma cholesterol remained < 160 mg/dl. After 7 mo, the LDLR-/- mice developed massive xanthomatous infiltration of the skin and subcutaneous tissue. The aorta and coronary ostia exhibited gross atheromata, and the aortic valve leaflets were thickened by cholesterol-laden macrophages. No such changes were seen in the LDLR-/- mice on a normal chow diet, nor in wild type mice that were fed either a chow diet or the high-fat diet. We conclude that LDL receptors are largely responsible for the resistance of wild type mice to atherosclerosis. The cholesterol-fed LDLR-/- mice offer a new model for the study of environmental and genetic factors that modify the processes of atherosclerosis and xanthomatosis.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8182121      PMCID: PMC294295          DOI: 10.1172/JCI117179

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  20 in total

Review 1.  Apolipoprotein B, the major protein component of triglyceride-rich and low density lipoproteins.

Authors:  L Chan
Journal:  J Biol Chem       Date:  1992-12-25       Impact factor: 5.157

2.  Technics for studying atherosclerotic lesions.

Authors:  R L HOLMAN; H C McGILL; J P STRONG; J C GEER
Journal:  Lab Invest       Date:  1958 Jan-Feb       Impact factor: 5.662

3.  Chylomicron remnant clearance from the plasma is normal in familial hypercholesterolemic homozygotes with defined receptor defects.

Authors:  D C Rubinsztein; J C Cohen; G M Berger; D R van der Westhuyzen; G A Coetzee; W Gevers
Journal:  J Clin Invest       Date:  1990-10       Impact factor: 14.808

4.  Natural history and cardiac manifestations of homozygous familial hypercholesterolaemia.

Authors:  B Haitas; S G Baker; T E Meyer; B I Joffe; H C Seftel
Journal:  Q J Med       Date:  1990-07

Review 5.  Cellular pathology of homozygous familial hypercholesterolemia.

Authors:  L M Buja; P T Kovanen; D W Bilheimer
Journal:  Am J Pathol       Date:  1979-11       Impact factor: 4.307

6.  Developmental and age-related changes in apolipoprotein B mRNA editing in mice.

Authors:  K Higuchi; K Kitagawa; K Kogishi; T Takeda
Journal:  J Lipid Res       Date:  1992-12       Impact factor: 5.922

7.  Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery.

Authors:  S Ishibashi; M S Brown; J L Goldstein; R D Gerard; R E Hammer; J Herz
Journal:  J Clin Invest       Date:  1993-08       Impact factor: 14.808

8.  Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells.

Authors:  A S Plump; J D Smith; T Hayek; K Aalto-Setälä; A Walsh; J G Verstuyft; E M Rubin; J L Breslow
Journal:  Cell       Date:  1992-10-16       Impact factor: 41.582

9.  Cadiovascular complications of homozygous familial hypercholesterolaemia.

Authors:  J M Allen; G R Thompson; N B Myant; R Steiner; C M Oakley
Journal:  Br Heart J       Date:  1980-10

10.  Apolipoprotein B (B-48) of rat chylomicrons is not a precursor of the apolipoprotein of low density lipoproteins.

Authors:  F M Van't Hooft; D A Hardman; J P Kane; R J Havel
Journal:  Proc Natl Acad Sci U S A       Date:  1982-01       Impact factor: 11.205

View more
  198 in total

1.  Suppression of diet-induced atherosclerosis in low density lipoprotein receptor knockout mice overexpressing lipoprotein lipase.

Authors:  M Shimada; S Ishibashi; T Inaba; H Yagyu; K Harada; J I Osuga; K Ohashi; Y Yazaki; N Yamada
Journal:  Proc Natl Acad Sci U S A       Date:  1996-07-09       Impact factor: 11.205

2.  Cloning of monoclonal autoantibodies to epitopes of oxidized lipoproteins from apolipoprotein E-deficient mice. Demonstration of epitopes of oxidized low density lipoprotein in human plasma.

Authors:  W Palinski; S Hörkkö; E Miller; U P Steinbrecher; H C Powell; L K Curtiss; J L Witztum
Journal:  J Clin Invest       Date:  1996-08-01       Impact factor: 14.808

3.  Elevated levels of SREBP-2 and cholesterol synthesis in livers of mice homozygous for a targeted disruption of the SREBP-1 gene.

Authors:  H Shimano; I Shimomura; R E Hammer; J Herz; J L Goldstein; M S Brown; J D Horton
Journal:  J Clin Invest       Date:  1997-10-15       Impact factor: 14.808

4.  Peroxisome Proliferator-activated receptor γ activation by ligands and dephosphorylation induces proprotein convertase subtilisin kexin type 9 and low density lipoprotein receptor expression.

Authors:  Yajun Duan; Yuanli Chen; Wenquan Hu; Xiaoju Li; Xiaoxiao Yang; Xin Zhou; Zhinan Yin; Deling Kong; Zhi Yao; David P Hajjar; Lin Liu; Qiang Liu; Jihong Han
Journal:  J Biol Chem       Date:  2012-05-16       Impact factor: 5.157

Review 5.  Cardiovascular gene therapy for myocardial infarction.

Authors:  Maria C Scimia; Anna M Gumpert; Walter J Koch
Journal:  Expert Opin Biol Ther       Date:  2013-12-16       Impact factor: 4.388

Review 6.  The emerging roles of β-arrestins in fibrotic diseases.

Authors:  Yuan-jing Gu; Wu-yi Sun; Sen Zhang; Jing-jing Wu; Wei Wei
Journal:  Acta Pharmacol Sin       Date:  2015-09-21       Impact factor: 6.150

7.  A₁ adenosine receptor deficiency or inhibition reduces atherosclerotic lesions in apolipoprotein E deficient mice.

Authors:  Bunyen Teng; Jonathan D Smith; Michael E Rosenfeld; Peggy Robinet; Mary E Davis; R Ray Morrison; S Jamal Mustafa
Journal:  Cardiovasc Res       Date:  2014-02-12       Impact factor: 10.787

8.  VLDL best predicts aortic root atherosclerosis in LDL receptor deficient mice.

Authors:  Paul A VanderLaan; Catherine A Reardon; Ronald A Thisted; Godfrey S Getz
Journal:  J Lipid Res       Date:  2008-10-28       Impact factor: 5.922

9.  Smooth Muscle Cell Reprogramming in Aortic Aneurysms.

Authors:  Pei-Yu Chen; Lingfeng Qin; Guangxin Li; Jose Malagon-Lopez; Zheng Wang; Sonia Bergaya; Sharvari Gujja; Alexander W Caulk; Sae-Il Murtada; Xinbo Zhang; Zhen W Zhuang; Deepak A Rao; Guilin Wang; Zuzana Tobiasova; Bo Jiang; Ruth R Montgomery; Lele Sun; Hongye Sun; Edward A Fisher; Jeffrey R Gulcher; Carlos Fernandez-Hernando; Jay D Humphrey; George Tellides; Thomas W Chittenden; Michael Simons
Journal:  Cell Stem Cell       Date:  2020-04-02       Impact factor: 24.633

10.  Hepatic overexpression of bovine scavenger receptor type I in transgenic mice prevents diet-induced hyperbetalipoproteinemia.

Authors:  S Wölle; D P Via; L Chan; J A Cornicelli; C L Bisgaier
Journal:  J Clin Invest       Date:  1995-07       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.